Journal for ImmunoTherapy of Cancer (Aug 2017)
Immunotherapy biomarkers 2016: overcoming the barriers
- Jeffrey Schlom,
- Lisa H Butterfield,
- Jianda Yuan,
- Alessandra Cesano,
- Janet Siebert,
- Barbara Seliger,
- Jay A. Berzofsky,
- James L. Gulley,
- Holden Maecker,
- Bernard A. Fox,
- Marcus O. Butler,
- Cristina Maccalli,
- Sacha Gnjatic,
- Vaios Karanikas,
- Ilan Kirsch,
- Sylvia Janetzki,
- Samir N. Khleif,
- Magdalena Thurin,
- Peter P. Lee,
- Shyam Kalavar,
- David F. Stroncek
Affiliations
- Jeffrey Schlom
- 2Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
- Lisa H Butterfield
- Aff21 0000 0004 0456 9819grid.478063.eDepartment of Medicine, Surgery and ImmunologyUniversity of Pittsburgh Cancer Institute 5117 Centre Avenue 15213 Pittsburgh PA USA
- Jianda Yuan
- Aff20 0000 0001 2260 0793grid.417993.1Early Clinical Oncology DevelopmentMerck Research Laboratories 07065 Rahway NJ USA
- Alessandra Cesano
- 6ESSA Pharma Inc., South San Francisco, CA, USA
- Janet Siebert
- Aff17 CytoAnalytics 3500 South Albion Street 80113 Cherry Hills Village CO USA
- Barbara Seliger
- Institute of Medical Immunology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Germany
- Jay A. Berzofsky
- Aff2 0000 0004 0483 9129grid.417768.bVaccine Branch, Center for Cancer Research 41 Medlars Dr, Bldg 41 Rm D702D 20892 Bethesda MD USA
- James L. Gulley
- Aff2 0000 0004 1936 8075grid.48336.3aGenitourinary Malignancies Branch, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Bethesda MD USA
- Holden Maecker
- Stanford University School of Medicine, Stanford, CA, USA
- Bernard A. Fox
- Aff5 grid.415337.7Earle A. Chiles Research Institute, Providence Cancer Center 4805 NE Glisan Street 97213 Portland OR USA
- Marcus O. Butler
- Aff3 grid.415224.40000 0001 2150 066XPrincess Margaret Cancer Center/Ontario Cancer Institute RM 9-622, 610 University Ave Toronto ON Canada
- Cristina Maccalli
- 3Sidra Medicine, Doha, Qatar
- Sacha Gnjatic
- Aff6 0000 0001 0670 2351grid.59734.3cDepartment of Hematology/Oncology, Tisch Cancer InstituteIcahn School of Medicine at Mount Sinai, S5-105 Box 1128 1470 Madison Avenue 10029 New York NY USA
- Vaios Karanikas
- 4F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Ilan Kirsch
- Adaptive Biotechnologies, Seattle, Washington, USA
- Sylvia Janetzki
- Aff5 ZellNet Consulting, Inc. 555 North Avenue 07024 Fort Lee NJ USA
- Samir N. Khleif
- Aff6 grid.410427.40000 0001 2284 9329Georgia Regents University Cancer Center Augusta GA France
- Magdalena Thurin
- Aff19 0000 0001 2297 5165grid.94365.3dNational Cancer Institute, Cancer Diagnosis Program, DCTD, National Institutes of Health 9609 Medical Center Drive 20892 Bethesda MD USA
- Peter P. Lee
- Aff9 0000 0004 0421 8357grid.410425.6Department of Immuno-Oncology, City of Hope 1500 East Duarte Road 91010 Duarte CA USA
- Shyam Kalavar
- Aff8 0000 0001 2285 9893grid.413579.dCenter for Devices and Radiological Health, U.S. Food and Drug Administration 1401 Rockville Pike 20852 Rockville MD USA
- David F. Stroncek
- Aff18 0000 0001 2297 5165grid.94365.3dDepartment of Transfusion MedicineNational Institutes of Health 10 Center Drive, Building 10, Room 3C720 20892 Bethesda MD USA
- DOI
- https://doi.org/10.1186/s40425-017-0225-6
- Journal volume & issue
-
Vol. 5,
no. 1
Abstract
This report summarizes the symposium, ‘Immunotherapy Biomarkers 2016: Overcoming the Barriers’, which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.
